Navigation Links
Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention
Date:5/12/2009

  • Genetic biomarkers, companion and triage diagnostics, and potential new applications for drug development for chronic disease
  • Biomarkers in Oncology, and future and forward looking aspects of biomarkers in drug development
  • Perspective of "Big Pharma" on use of molecular diagnostics in drug development, business models for incorporation of biomarkers, and reimbursement concerns and issues
  • A case study on biomarkers in the development of new drugs

    • About BIO

    BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

    About Interleukin Genetics

    Interleukin Genetics, Inc. (NYSE Amex: ILI), is a genetics-focused personalized health company that develops preventative consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin Genetics uses its leading genetics research and scientific capabilities to develop and test innovative preventative and therapeutic products. Interleukin Genetics is headquartered in Waltham, MA. For more information about Interleukin Genetics, its products and ongoing programs, please visit http://www.ilgenetics.com.

    <
    '/>"/>

    SOURCE Interleukin Genetics, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3

    Related medicine news :

    1. Interleukin Genetics Announces Conference Call to Discuss First Quarter 2009 Results
    2. Interleukin Genetics Grants LABEC Pharma a License for Sales and Distribution of Its Heart Health Genetic Test
    3. Interleukin Genetics Receives NYSE Amex Staff Determination, Requests Oral Hearing Before the Listing Qualifications Panel
    4. Interleukin Genetics Announces Conference Call to Discuss Fourth Quarter 2008 Results
    5. Interleukin Genetics to Present at G-2 Reports Molecular Diagnostic Conference
    6. Interleukin Genetics Submits Plan to Regain Compliance with Continued Listing Standards
    7. Interleukin Genetics to Present Data Highlighting Link Between Inflammatory Gene Variations and Less Effective Weightloss
    8. Novel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants
    9. Interleukin Genetics Announces Conference Call and Webcast to Discuss Third Quarter 2008 Business Results
    10. Interleukin Genetics to Present at Rodman & Renshaw 10th Annual Healthcare Conference
    11. Interleukin-12 indicates survival prospects for melanoma patients

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/24/2009)... Dr. Tom Lintner is embra...expand his reach and keep an ongoing dialogue with...cial media outlets, Dr. Lintner provides informati...d seeks to answer any questions that patients may ...s) November 24, 2009 -- A plastic surgeon in Atla...
    (Date:11/24/2009)... Sinusitis patients life ...c sinusitis, Sinus Dynamics non-invasive nasal sin...nience of treating all types of Sinusitis without ... sinus surgery. Researchers found 82.9% of patient...ed antibiotics with mean particle diameter of 3.2 ...
    (Date:11/24/2009)... Developed by Opticom Dat...evice for self-examination of the eye. , ...er 24, 2009 -- FloatScope is a new hand-held devic...help monitor various ocular health conditions such...ens as well as the functioning of the iris., , , F...
    (Date:11/23/2009)... Researchers from the University of Michigan dete...million Americans with hepatitis C virus (HCV) inf... 2007. Treatment rates appear to be declining, in...are infected. If this disturbing trend continues,...m HCV will be prevented by antiviral therapy. Thi...
    (Date:11/23/2009)...,, WASHINGTON,Nov.23/PRNewswire/--TheLupusFou...lcelebrate35yearsofsuccessprovidingfreeday-to-daye...lupusandtheirfamiliesinthegreaterD.C.area.LFAGW,s3...om12:00p.m.-2:30p.m.atB.Smith,s,50MassachusettsAve...tedticketsareavailableat$100each.Tablesponsoroppor...
    Breaking Medicine News(10 mins):Health News:Atlanta Plastic Surgeon Using Social Media To Connect with Patients 2Health News:Atlanta Plastic Surgeon Using Social Media To Connect with Patients 3Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 2Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 3Health News:Sinusitis Treatment Using Nebulized Medications to Treat Sinusitis Rather than Sinus Surgery 4Health News:FloatScope - A New Device for Self-Viewing Eye Floaters 2Health News:Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US 2Health News:Washington Lupus Chapter Celebrates 35th Anniversary on December 5 2
    ...MERSET, N.J., Dec. 3 inVentiv Health, Inc.,(Nasda...ts upcoming Investor,Day, which will be held Tuesd...t will be begin at 8:30 a.m., not 9:00 a.m. as ann...he four major divisions, and a look at inVentiv,s,...
    ...search shows men experienced almost 100% increase ...or couples worldwide, erectile,dysfunction (ED) is...ity to,perform. As millions of men in America each...hed study reveals that,Prelox(R), a patented and p...
    ..., For couples worldwide, erectile dysfunction (ED)...bility to perform. As millions of men in America ...ve treatments to prescription medications and surg... an antioxidant plant extract from the bark of the...
    ... The job situation for 2006 chemistry graduates re...n the previous two years, but full-time jobs remai...ng the second half of the booming 1990s, reports t...ar of technical work before graduation remained un...
    ... Although they look normal, people suffering from ... as ugly and disfigured. New imaging research rev...l, but function abnormally when processing visual ...or patients distorted body image. , Our discove...
    ... Metabolic syndrome is a condition afflicting one ... an established pre-cursor to diabetes, coronary h...s have long been advised to eat a low-fat diet eve...syndrome. Now, a new study indicates that a diet l...
    Other Medicine News:Health News:inVentiv Health Provides Updated Information on December 11th Investor Day 2Health News:inVentiv Health Provides Updated Information on December 11th Investor Day 3Health News:Horphag's Prelox(R) Provides Over-the-Counter Solution in Battle Against Erectile Dysfunction 2Health News:Horphag's Prelox(R) Provides Over-the-Counter Solution in Battle Against Erectile Dysfunction 3Health News:Horphag's Prelox(R) Provides Over-the-Counter Solution in Battle Against Erectile Dysfunction 4Health News:Horphag's Prelox provides over-the-counter solution 2Health News:Horphag's Prelox provides over-the-counter solution 3Health News:Distorted self-image due to visual brain glitch, UCLA research finds 2Health News:Distorted self-image due to visual brain glitch, UCLA research finds 3Health News:Low-carb diet reduces inflammation and blood saturated fat in metabolic syndrome 2
    (Date:11/23/2009)...--ProteonTherapeutics,Inc.,hasinitiatedaPhase1/2hu...gerenaldisease(ESRD)patientsundergoingsurgeryforar...sProteon,ssecondhumanclinicalstudyinhemodialysispa...2studyofPRT-201inESRDpatientsundergoingsurgeryfora...oteonalsoannouncestheappointmentofboardmemberGrego...
    (Date:11/23/2009)...Call/--CordBloodAmerica,Inc.(OTCBulletinBoard:CBAI...( http://www.cordblood-america.com )focusedonbring...surancepolicy,tofamiliesnationwideandinternational...hCEOandco-founderMatthewSchisslerisnowavailable. ,...875811 . ,, Intheinterview,Mr.Schisslerupdatesp...
    (Date:11/23/2009)...-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS )announc...oche(SWX:ROG.VX;RO.S,OTCQX:RHHBY),willcontinuefort...se2btrialofRG7128,afirst-in-classnucleosideanalogp...sCvirus(HCV)infection.Thedecisionwasreachedafteras...ee(DMC)ofallavailablesafetydatafromthefirstcohorto...
    Breaking Medicine Technology:Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4WebMD to Present at the 2009 Citi Investment Research Small and Mid Cap Conference 6355 1News brief 3A Adverse symptom reporting by patients vs clinicians 61572 1News brief 3A Adverse symptom reporting by patients vs clinicians 61572 2To eat or not to eat 3F Mental budgets help control consumption 61569 1To eat or not to eat 3F Mental budgets help control consumption 61569 2
    ...N.Y., Sept. 2 The many recent reports,documenting...s (siRNAs) in,animal models of human disease may a...ects related to the ability of siRNA to activate a...tember 2008 issue (Volume 19,Number 9) of ,Human G...Mary Ann Liebert, Inc. The paper, which was publis...
    ...al - New Choices for This Common and Successful Su...ghts from the September issue of Mayo Clinic Healt...s you wish. Reprinting is allowed for a,fee. Mayo ...ude the,following subscription information as your...thLetter.MayoClinic.com or call toll-free for sub...
    Other Medicine Technology:Previous Claims of siRNA Therapeutic Effects Called into Question by Report in 'Human Gene Therapy' 2Previous Claims of siRNA Therapeutic Effects Called into Question by Report in 'Human Gene Therapy' 3September 2008 Mayo Clinic Health Letter Highlights Cataract Removal, Severe Headache and Dual Energy X-Ray Imaging 2September 2008 Mayo Clinic Health Letter Highlights Cataract Removal, Severe Headache and Dual Energy X-Ray Imaging 3September 2008 Mayo Clinic Health Letter Highlights Cataract Removal, Severe Headache and Dual Energy X-Ray Imaging 4
    ...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
    ...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
    ...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
    ...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
    Medicine Products: